Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion
The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well
- 24 10 2022
- |